TERE1 activation of CYP3A4 is consistent with reports of SXR-induced CYP3A4, which hydroxylates testosterone and progesterone leading to inactive metabolites and resulted in inhibition of androgen-dependent growth of human LAPC-4 prostate cancer cells [43, 47]. This evidence concerns the gene CYP3A4 and prostate cancer.